Cancer Research Cancer Research Funding Available  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beverloo, H. B.
Right arrow Articles by Slater, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beverloo, H. B.
Right arrow Articles by Slater, R.
[Cancer Research 61, 5374-5377, July 15, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Fusion of the Homeobox Gene HLXB9 and the ETV6 Gene in Infant Acute Myeloid Leukemias with the t(7;12)(q36;p13)1

H. Berna Beverloo2,, 3, Ioannis Panagopoulos2, Magareth Isaksson, Elisabeth van Wering, Ellen van Drunen, Annelies de Klein, Bertil Johansson and Rosalyn Slater

Departments of Cell Biology and Genetics [H. B. B., E. v. D., R. S.] and Clinical Genetics [A. d. K., R. S.], Erasmus University Rotterdam, 3000 DR Rotterdam, the Netherlands; Dutch Childhood Leukemia Study Group, 2504 AM The Hague, the Netherlands [E. v. W.]; and Department of Clinical Genetics, University Hospital, SE-22185 Lund, Sweden [I. P., M. I., B. J.]

Recently, we and others reported a recurrent t(7;12)(q36;p13) found in myeloid malignancies in children <=18 months of age and associated with a poor prognosis. Fluorescence in situ hybridization studies mapped the 12p13 breakpoint to the first intron of ETV6 and narrowed down the region of 7q36 involved. By using the sequences made public recently by the Human Genome Project, two candidate genes in 7q36 were identified: the homeobox gene HLXB9 and c7orf3, a gene with unknown function. Reverse transcription-PCR of two cases with t(7;12), using primers for c7orf3 and ETV6, was negative. However, reverse transcription-PCR for HLXB9-ETV6 demonstrated alternative splicing; the two major bands corresponded to fusion of exon 1 of HLXB9 to exons 2 and 3, respectively, of ETV6. The reciprocal ETV6-HLXB9 transcript was not detected. It remains to be elucidated if the leukemic phenotype is attributable to the formation of the HLXB9-ETV6 fusion protein, which includes the helix-loop-helix and E26 transformation-specific DNA binding domains of ETV6 or to the disruption of the normal ETV6 protein.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
S. W. Scherer and E. D. Green
Human chromosome 7 circa 2004: a model for structural and functional studies of the human genome
Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R303 - R313.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.